🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great talk by Dr. Christian Rolfo receiving Robert Livingston Lecture Award at SWOG adoring meeting!

Congratulation to a great colleague and friend! Well deserved!

Great opening of the annual lung cancer summit in Rome. Thanks to the organizers Drs. Cappuzzo, Landi and Cascone ( MD Anderson Cancer Center).

Great discussion about early stage lung cancer treatment in Rome by Drs. Cascone, Peters and Cappuzzo.

Save the date!

Great and fun meeting in Rome!

Rome 2025! Great to meet colleagues and friends!

Great visit in Nanchang, China!

Very nice retirement party for a giant in lung cancer, Dr. Chandra Belani at ASCO in Chicago.

Encouraging results for chemo free regimen of adagrasib plus pembrolizumab in first line for pts with KRAS G12C NSCLC .

Do we have a future AI based bio marker for TROP 2? Validation needed!

At ASCO: Olomorasib plus Pembrolizumab with high response in 1. Line therapy for NSCLC KRAS G12 C patients.

Fran ASCO 25: Final results from neoadjuvant CM 816 study.

Great results in small cell lung cancer with Tarlatamab as 2 line therapy. Most likely new standard of care with manageable toxicity !

Presented at ASCO today:

Great meeting with BioNTech leadership at Mount Sinai last week and great meeting the CMO Dr. Özlem Türecı, who was pivotal in the development of COVID 19 vaccine! Thanks to Dr. Miriam Merad for organizing.

High productivity in the NIH Lung SPORE program over the last 5 years.

Great “Best of ASCO 25” arranged by the New York Lung Cancer Foundation. Here Dr. Josh Sabari from NYU summarizing KRAS therapy!

Approval of TROP 2 ADC in EGFR+ NSCLC previously treated with EGFR TKI(s).